INS and metabolic dysfunction-associated steatotic liver disease: Moreover, the effect of pioglitazone, an insulin sensitizer, in reversing NAFLD is limited, suggesting that other factors play critical roles in NAFLD and that NAFLD could precede the development of the metabolic syndrome [4].